Compounds > acridines
Page last updated: 2024-08-21

acridines and Disease Exacerbation

acridines has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horiuchi, M; Huang, PL; Morishita, T; Nakashima, Y; Sasaguri, Y; Suda, O; Tanimoto, A; Tasaki, H; Tsutsui, M; Yanagihara, N1
Balasubramaniam, S; Baron, AT; Boardman, CH; Lafky, JM; Maihle, NJ; Podratz, KC; Suman, VJ1
Miller, DM; Stewart, DA; Thomas, SD; Xu, X1

Other Studies

3 other study(ies) available for acridines and Disease Exacerbation

ArticleYear
Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Circulation, 2002, Sep-24, Volume: 106, Issue:13

    Topics: Acridines; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Coronary Artery Disease; Coronary Vessels; Cyclic GMP; Disease Progression; Luminescent Measurements; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Peptidyl-Dipeptidase A; Time

2002
Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999, Volume: 8, Issue:2

    Topics: Acridines; Adult; Aged; Biomarkers, Tumor; Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; Disease Progression; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunosorbent Techniques; Laparotomy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Proto-Oncogene Mas; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tumor Cells, Cultured

1999
Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.
    Nucleic acids research, 2002, Jun-01, Volume: 30, Issue:11

    Topics: Acridines; Animals; Apoptosis; Base Sequence; Blotting, Western; Cell Division; Cisplatin; Disease Progression; Drug Synergism; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Genes, myc; In Situ Nick-End Labeling; Melanoma; Mice; Mice, Inbred C57BL; Oligonucleotides, Antisense; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured

2002